$SEM
SELECT MEDICAL HOLDINGS CORP Stock $sem

$sem Overview Financials Valuation SEC Filings Company Website

2018 Form 10-K Financial Statement

#000162828019001659 Filed on February 21, 2019

Income Statement

Concept	2018	2017 Q4	2017 Q3
Revenue	$5.081B	$1.114B	$1.077B
YoY Change	14.35%	6.51%	2.2%
Cost Of Revenue	$4.341B	$946.9M	$939.1M
YoY Change	16.25%	4.07%	2.55%
Gross Profit	$740.2M	$147.4M	$137.9M
YoY Change	4.34%	8.06%	-0.12%
Gross Profit Margin	14.57%	13.23%	12.81%
Selling, General & Admin	$121.3M	$30.60M	$27.10M
YoY Change	6.4%	-29.17%	-39.51%
% of Gross Profit	16.39%	20.76%	19.65%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$171.7M	$40.40M	$38.70M
YoY Change	20.41%	8.02%	4.03%
% of Gross Profit	23.2%	27.41%	28.06%
Operating Expenses	$322.9M	$71.00M	$65.80M
YoY Change	17.85%	-12.02%	-19.66%
Operating Profit	$417.3M	$76.35M	$72.10M
YoY Change	17.25%	36.97%	28.38%
Interest Expense	$198.5M	-$33.10M	-$33.30M
YoY Change	28.31%	-10.3%	-15.05%
% of Operating Profit	47.57%	-43.35%	-46.19%
Other Income/Expense, Net
YoY Change
Pretax Income	$235.6M	$43.30M	$38.84M
YoY Change	16.34%	77.46%	661.59%
Income Tax	$58.61M	-$6.300M	$14.02M
% Of Pretax Income	24.88%	-14.55%	36.09%
Net Earnings	$137.8M	$100.8M	$18.46M
YoY Change	-22.21%	399.69%	185.3%
Net Earnings / Revenue	2.71%	9.04%	1.71%
Basic Earnings Per Share	$1.02	$0.75	$0.14
Diluted Earnings Per Share	$1.02	$0.75	$0.14
COMMON SHARES
Basic Shares Outstanding	130.2M shares		129.1M shares
Diluted Shares Outstanding	130.3M shares		129.3M shares

Balance Sheet

Concept	2018	2017 Q4	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$175.2M	$122.5M	$107.3M
YoY Change	43.02%	23.74%	57.33%
Cash & Equivalents	$175.2M	$122.5M	$107.3M
Short-Term Investments
Other Short-Term Assets	$110.6M	$75.16M	$80.30M
YoY Change	3.75%	-3.27%	-44.54%
Inventory
Prepaid Expenses
Receivables	$706.7M	$691.7M	$716.4M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$992.5M	$920.8M	$904.1M
YoY Change	7.79%	20.7%	12.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$979.8M	$912.6M	$946.1M
YoY Change	7.36%	2.28%	9.57%
Goodwill		$2.783B
YoY Change		1.16%
Intangibles		$326.5M
YoY Change		-4.12%
Long-Term Investments	$230.7M
YoY Change
Other Assets	$2.800M	$184.4M	$174.8M
YoY Change	-98.48%	6.02%	7.04%
Total Long-Term Assets	$4.972B	$4.206B	$4.220B
YoY Change	18.2%	1.17%	4.46%
TOTAL ASSETS
Total Short-Term Assets	$992.5M	$920.8M	$904.1M
Total Long-Term Assets	$4.972B	$4.206B	$4.220B
Total Assets	$5.964B	$5.127B	$5.124B
YoY Change	16.33%	4.2%	5.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$146.7M	$128.2M	$133.3M
YoY Change	14.43%	1.29%	16.73%
Accrued Expenses	$485.9M	$416.5M	$403.0M
YoY Change	16.66%	6.22%	2.73%
Deferred Revenue
YoY Change
Short-Term Debt	$25.10M	$29.50M	$18.90M
YoY Change	-14.92%	-25.13%	-6.44%
Long-Term Debt Due	$43.90M	$22.20M	$37.60M
YoY Change	97.75%	62.04%	196.06%
Total Short-Term Liabilities	$705.2M	$605.4M	$599.5M
YoY Change	16.48%	5.91%	8.94%
LONG-TERM LIABILITIES
Long-Term Debt	$3.250B	$2.678B	$2.753B
YoY Change	21.35%	-0.28%	4.19%
Other Long-Term Liabilities	$158.9M	$145.7M	$138.1M
YoY Change	9.06%	6.73%	1.17%
Total Long-Term Liabilities	$3.408B	$145.7M	$2.891B
YoY Change	20.72%	6.73%	4.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$705.2M	$605.4M	$599.5M
Total Long-Term Liabilities	$3.408B	$145.7M	$2.891B
Total Liabilities	$5.161B	$3.554B	$4.402B
YoY Change	19.92%	-1.08%	13.56%
SHAREHOLDERS EQUITY
Retained Earnings		$359.7M
YoY Change		-3.22%
Common Stock		$463.6M
YoY Change		4.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$803.0M	$823.4M	$721.6M
YoY Change
Total Liabilities & Shareholders Equity	$5.964B	$5.127B	$5.124B
YoY Change	16.33%	4.2%	5.75%

Cashflow Statement

Concept	2018	2017 Q4	2017 Q3
OPERATING ACTIVITIES
Net Income	$137.8M	$100.8M	$18.46M
YoY Change	-22.21%	399.69%	185.3%
Depreciation, Depletion And Amortization	$171.7M	$40.40M	$38.70M
YoY Change	20.41%	8.02%	4.03%
Cash From Operating Activities	$494.2M	$108.1M	$89.70M
YoY Change	107.53%	64.29%	-12.57%
INVESTING ACTIVITIES
Capital Expenditures	-$167.3M	-$59.40M	-$68.50M
YoY Change	-28.26%	37.18%	80.26%
Acquisitions	$523.1M
YoY Change	1809.95%
Other Investing Activities	-$529.9M	$36.50M	-$2.400M
YoY Change	-1414.89%	-176.04%	-134.29%
Cash From Investing Activities	-$697.1M	-$23.00M	-$70.90M
YoY Change	261.28%	-74.81%	128.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$255.6M	-69.90M	14.70M
YoY Change	-1280.69%	-224.16%	-117.99%
NET CHANGE
Cash From Operating Activities	$494.2M	108.1M	89.70M
Cash From Investing Activities	-$697.1M	-23.00M	-70.90M
Cash From Financing Activities	$255.6M	-69.90M	14.70M
Net Change In Cash	$52.63M	15.20M	33.50M
YoY Change	123.76%	-50.65%	-431.68%
FREE CASH FLOW
Cash From Operating Activities	$494.2M	$108.1M	$89.70M
Capital Expenditures	-$167.3M	-$59.40M	-$68.50M
Free Cash Flow	$661.5M	$167.5M	$158.2M
YoY Change	40.35%	53.53%	12.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0001320414
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2018	dei	Entity Small Business EntitySmallBusiness	false
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2018	sem	Defined Contribution Plan Employers Matching Contribution Vesting Period DefinedContributionPlanEmployersMatchingContributionVestingPeriod	P3Y
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	134114715	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	135265864	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	134114715	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	135265864	shares
CY2016	us-gaap	Earnings Per Share Basic Distributed EarningsPerShareBasicDistributed	0
CY2017	us-gaap	Earnings Per Share Basic Distributed EarningsPerShareBasicDistributed	0
CY2016	us-gaap	Earnings Per Share Diluted Distributed EarningsPerShareDilutedDistributed	0
CY2017	us-gaap	Earnings Per Share Diluted Distributed EarningsPerShareDilutedDistributed	0
CY2018	us-gaap	Earnings Per Share Diluted Distributed EarningsPerShareDilutedDistributed	0
CY2017Q4	us-gaap	Loss Contingency Accrual Insurance Related Assessment Discount Rate LossContingencyAccrualInsuranceRelatedAssessmentDiscountRate	0.03
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	600000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	291775	shares
CY2018	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	4472000	USD
CY2018	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	9409000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	3320726000	USD
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	373019000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	46500000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	326519000	USD
CY2018Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	516392000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	78699000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	437693000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	102908000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	125435000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	79364000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	118270000	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	9071000	USD
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3671000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	105000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.26
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.18
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P10M24D
CY2016	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0	shares
CY2017	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0	shares
CY2018	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0	shares
CY2018	dei	Document Type DocumentType	10-K
CY2018	dei	Entity Registrant Name EntityRegistrantName	SELECT MEDICAL HOLDINGS CORP
CY2018Q2	dei	Entity Public Float EntityPublicFloat	1963731627	USD
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	135262167	shares
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122549000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175178000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	691732000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	706676000	USD
CY2017Q4	us-gaap	Prepaid Taxes PrepaidTaxes	31387000	USD
CY2018Q4	us-gaap	Prepaid Taxes PrepaidTaxes	20539000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	75158000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	90131000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	920826000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	992524000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	912591000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	979810000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	2782812000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	3320726000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	326519000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	437693000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	184418000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	233512000	USD
CY2017Q4	us-gaap	Assets Assets	5127166000	USD
CY2018Q4	us-gaap	Assets Assets	5964265000	USD
CY2017Q4	sem	Book Overdrafts BookOverdrafts	29463000	USD
CY2018Q4	sem	Book Overdrafts BookOverdrafts	25083000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	22187000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	43865000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	128194000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	146693000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	160562000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	172386000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	605403000	USD
CY2017Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	92875000	USD
CY2018Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	110660000	USD
CY2017Q4	us-gaap	Interest Payable Current InterestPayableCurrent	19885000	USD
CY2018Q4	us-gaap	Interest Payable Current InterestPayableCurrent	12137000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	143166000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	190691000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	705186000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2677715000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3249516000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	124917000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	153895000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	145709000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	158940000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	3553744000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	4267537000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	640818000	USD
CY2018Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	780488000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	134000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	135000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	463499000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	482556000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	359735000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	320351000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	823368000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	803042000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	109236000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	113198000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	932604000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	916240000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5127166000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5964265000	USD
CY2016	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4217460000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4365245000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5081258000	USD
CY2016	us-gaap	Cost Of Services Excluding Depreciation Depletion And Amortization CostOfServicesExcludingDepreciationDepletionAndAmortization	3665375000	USD
CY2017	us-gaap	Cost Of Services Excluding Depreciation Depletion And Amortization CostOfServicesExcludingDepreciationDepletionAndAmortization	3735309000	USD
CY2018	us-gaap	Cost Of Services Excluding Depreciation Depletion And Amortization CostOfServicesExcludingDepreciationDepletionAndAmortization	4341056000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	106927000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	114047000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	121268000	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	145311000	USD
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	160011000	USD
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	201655000	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	3917613000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	4009367000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	4663979000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	299847000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	355878000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	417279000	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11626000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19719000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14155000	USD
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19943000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21054000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21905000	USD
CY2016	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	42651000	USD
CY2017	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-49000	USD
CY2018	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	9016000	USD
CY2016	us-gaap	Interest Expense InterestExpense	170081000	USD
CY2017	us-gaap	Interest Expense InterestExpense	154703000	USD
CY2018	us-gaap	Interest Expense InterestExpense	198493000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	180734000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	202461000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	235552000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55464000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18184000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58610000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	125270000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	220645000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	176942000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9859000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43461000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	39102000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	115411000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	137840000	USD
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.88
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.02
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.87
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.33
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.02
CY2015Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	238221000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	908517000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	115411000	USD
CY2016	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	12479000	USD
CY2016	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-2620000	USD
CY2016	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2016	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	16640000	USD
CY2016	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	2929000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1672000	USD
CY2016	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	50178000	USD
CY2016	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	2514000	USD
CY2016	sem	Temporary Equity Distributions To Non Controlling Interests TemporaryEquityDistributionsToNonControllingInterests	5984000	USD
CY2016	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	6670000	USD
CY2016	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	177216000	USD
CY2016	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-177216000	USD
CY2016	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	227000	USD
CY2016	us-gaap	Stockholders Equity Other StockholdersEquityOther	-400000	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	422159000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	905901000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2017	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	35639000	USD
CY2017	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	7822000	USD
CY2017	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2017	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	18291000	USD
CY2017	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4753000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2017000	USD
CY2017	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	18280000	USD
CY2017	sem	Temporary Equity Distributions To Non Controlling Interests TemporaryEquityDistributionsToNonControllingInterests	5334000	USD
CY2017	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	5286000	USD
CY2017	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	187506000	USD
CY2017	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-187506000	USD
CY2017	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	848000	USD
CY2017	us-gaap	Stockholders Equity Other StockholdersEquityOther	-654000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	640818000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	932604000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	137840000	USD
CY2018	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	27775000	USD
CY2018	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	11327000	USD
CY2018	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2018	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	20443000	USD
CY2018	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	6837000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1722000	USD
CY2018	sem	Temporary Equity Exchange Of Equity Interest TemporaryEquityExchangeOfEquityInterest	163659000	USD
CY2018	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	77815000	USD
CY2018	sem	Temporary Equity Distributions To Non Controlling Interests TemporaryEquityDistributionsToNonControllingInterests	217570000	USD
CY2018	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	95388000	USD
CY2018	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	164476000	USD
CY2018	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-164476000	USD
CY2018	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	1330000	USD
CY2018	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1190000	USD
CY2018Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	780488000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	916240000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	125270000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	220645000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	176942000	USD
CY2016	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	20476000	USD
CY2017	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	20006000	USD
CY2018	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	15721000	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	145311000	USD
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	160011000	USD
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	201655000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	532000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1133000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-103000	USD
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19943000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21054000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21905000	USD
CY2016	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	11626000	USD
CY2017	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	6527000	USD
CY2018	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	2999000	USD
CY2016	sem	Gain Losson Dispositionof Assetsand Businesses GainLossonDispositionofAssetsandBusinesses	46488000	USD
CY2017	sem	Gain Losson Dispositionof Assetsand Businesses GainLossonDispositionofAssetsandBusinesses	10349000	USD
CY2018	sem	Gain Losson Dispositionof Assetsand Businesses GainLossonDispositionofAssetsandBusinesses	9168000	USD
CY2016	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	2779000	USD
CY2017	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	0	USD
CY2018	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	0	USD
CY2016	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	5339000	USD
CY2017	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2018	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	17413000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	19284000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	23326000	USD
CY2016	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	15656000	USD
CY2017	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11130000	USD
CY2018	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	13112000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12591000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-72324000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7217000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-29241000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	118833000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-54575000	USD
CY2016	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-17450000	USD
CY2017	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1597000	USD
CY2018	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	4152000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-9290000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	886000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-7857000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-15492000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3903000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1778000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	46292000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	17341000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	27896000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	346603000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	238131000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	494194000	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	472206000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	27390000	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	523134000	USD
CY2016	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	161633000	USD
CY2017	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	233243000	USD
CY2018	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	167281000	USD
CY2016	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	4723000	USD
CY2017	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	12682000	USD
CY2018	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	13482000	USD
CY2016	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	80463000	USD
CY2017	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	80350000	USD
CY2018	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	6760000	USD
CY2016	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	3779000	USD
CY2017	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2018	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-554320000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-192965000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-697137000	USD
CY2016	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	575000000	USD
CY2017	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	970000000	USD
CY2018	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	595000000	USD
CY2016	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	655000000	USD
CY2017	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	960000000	USD
CY2018	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	805000000	USD
CY2016	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	795344000	USD
CY2017	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	1139487000	USD
CY2018	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	779823000	USD
CY2016	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	438034000	USD
CY2017	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1179442000	USD
CY2018	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	11500000	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4392000	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1639000	USD
CY2016	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	27721000	USD
CY2017	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	46621000	USD
CY2018	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	42218000	USD
CY2016	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	21401000	USD
CY2017	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	20647000	USD
CY2018	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	25242000	USD
CY2016	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	2929000	USD
CY2017	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	4753000	USD
CY2018	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	6837000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1672000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2017000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1722000	USD
CY2016	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	10746000	USD
CY2017	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	-9899000	USD
CY2018	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	-4380000	USD
CY2016	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	11846000	USD
CY2017	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	9982000	USD
CY2018	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	2926000	USD
CY2016	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	12654000	USD
CY2017	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	10620000	USD
CY2018	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	311519000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	292311000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21646000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	255572000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	84594000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	23520000	USD
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	52629000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14435000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99029000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122549000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99029000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122549000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175178000	USD
CY2016	us-gaap	Interest Paid Net InterestPaidNet	142640000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	149156000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	193406000	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	70756000	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	64991000	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	48153000	USD
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	32861000	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	30043000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	29134000	USD
CY2016Q4	us-gaap	Business Acquisition Equity Interest Issued Or Issuable Value Assigned BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned	0	USD
CY2017Q4	us-gaap	Business Acquisition Equity Interest Issued Or Issuable Value Assigned BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned	0	USD
CY2018Q4	us-gaap	Business Acquisition Equity Interest Issued Or Issuable Value Assigned BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned	238000000	USD
CY2018Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	47	state
CY2018	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	business_segment
CY2018	us-gaap	Use Of Estimates UseOfEstimates	Use of EstimatesThe preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingencies, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but not limited to: amounts realizable for services performed, estimated useful lives of assets, the valuation of intangible assets, amounts payable for self-insured losses, and the computation of income taxes. Future events and their effects cannot be predicted with certainty; accordingly, the Company’s accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s operating environment changes. The Company’s management evaluates and updates assumptions and estimates on an ongoing basis. Actual results could differ from those estimates.
CY2018	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Credit Risk and Payor Concentrations<div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash balances and trade receivables. The Company’s excess cash is held with large financial institutions. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company’s facilities and are insured under third-party payor agreements. The Company’s general policy is to verify insurance coverage prior to the date of admission for patients admitted to the Company’s critical illness recovery hospitals and rehabilitation hospitals. Within the Company’s outpatient rehabilitation clinics, the Company verifies insurance coverage prior to the patient’s visit. Within the Company’s Concentra centers, the Company verifies insurance coverage or receives authorization from the patient’s employer prior to the patient’s visit. </span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Because of the geographic diversity of the Company’s facilities and non-governmental third-party payors, Medicare represents the Company’s only significant concentration of credit risk. Approximately </span><span style="font-family:inherit;font-size:10pt;"><span>27%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>16%</span></span><span style="font-family:inherit;font-size:10pt;color:#ff0000;"> </span><span style="font-family:inherit;font-size:10pt;">of the Company’s accounts receivable are from Medicare at December 31, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, respectively. The Company’s primary collection risks relate to non-governmental payors and deductibles, co-payments, and amounts owed by the patient. Deductibles, co-payments, and self-insured amounts owed by the patient are an immaterial portion of the Company’s accounts receivable balance. Approximately </span><span style="font-family:inherit;font-size:10pt;"><span>0.3%</span></span><span style="font-family:inherit;font-size:10pt;"> of the Company’s accounts receivable were from deductibles, co-payments, and self-insured amounts owed by patients at both </span><span style="font-family:inherit;font-size:10pt;">December 31, 2017</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">. </span></div><span style="font-family:inherit;font-size:10pt;">A significant portion of the Company’s net operating revenues are generated directly from the Medicare program. Net operating revenues generated directly from the Medicare program represented approximately </span><span style="font-family:inherit;font-size:10pt;"><span>30%</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>30%</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>27%</span></span><span style="font-family:inherit;font-size:10pt;"> of the Company’s total net operating revenues for the years ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2018</span>, respectively. As a provider of services under the Medicare program, the Company is subject to extensive regulations. The inability of any of the Company’s critical illness recovery hospitals, rehabilitation hospitals, or outpatient rehabilitation clinics to comply with Medicare regulations can result in significant changes in the net operating revenues generated from the Medicare program.
CY2016	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4217460000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4365245000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	532000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1133000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	532000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1133000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-29241000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	118833000	USD
CY2017Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	691732000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	691732000	USD
CY2016	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	4339551000	USD
CY2017	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	4903612000	USD
CY2018	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	5128838000	USD
CY2016	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	113590000	USD
CY2017	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	170689000	USD
CY2018	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	140488000	USD
CY2017Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets VariableInterestEntityConsolidatedCarryingAmountAssets	108200000	USD
CY2018Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets VariableInterestEntityConsolidatedCarryingAmountAssets	166200000	USD
CY2017Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Liabilities VariableInterestEntityConsolidatedCarryingAmountLiabilities	105700000	USD
CY2018Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Liabilities VariableInterestEntityConsolidatedCarryingAmountLiabilities	164400000	USD
CY2016	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	35600000	USD
CY2018	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	8600000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1543255000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1744391000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	630664000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	764581000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	912591000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	979810000	USD
CY2016	us-gaap	Depreciation Depreciation	129000000.0	USD
CY2017	us-gaap	Depreciation Depreciation	142600000	USD
CY2018	us-gaap	Depreciation Depreciation	171700000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	2751000000	USD
CY2017	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	31986000	USD
CY2017	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-174000	USD
CY2017	us-gaap	Goodwill Transfers GoodwillTransfers	0	USD
CY2017Q4	us-gaap	Goodwill Goodwill	2782812000	USD
CY2018	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	542851000	USD
CY2018	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	4472000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	182272000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	243705000	USD
CY2018Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	3222705000	USD
CY2018	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	9016000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	37113000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	43792000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	13751000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	16338000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	131408000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	183575000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	182272000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	243705000	USD
CY2016	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	320078000	USD
CY2017	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	336349000	USD
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	393034000	USD
CY2016	sem	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	274952000	USD
CY2017	sem	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	289224000	USD
CY2018	sem	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	342603000	USD
CY2016	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	43410000	USD
CY2017	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	45648000	USD
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	48535000	USD
CY2016	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	164200000	USD
CY2017	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	178100000	USD
CY2018	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	216900000	USD
CY2016	sem	Loss On Sale Of Stock In Subsidiary Or Equity Method Investee LossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	-5100000	USD
CY2016	sem	Gain On Sale Of Stock In Subsidiary Or Equity Method Investee GainOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	2500000	USD
CY2018Q4	us-gaap	Loss Contingency Accrual Insurance Related Assessment Discount Rate LossContingencyAccrualInsuranceRelatedAssessmentDiscountRate	0.03
CY2017Q4	us-gaap	Loss Contingency Discounted Amount Of Insurance Related Assessment Liability LossContingencyDiscountedAmountOfInsuranceRelatedAssessmentLiability	157100000	USD
CY2018Q4	us-gaap	Loss Contingency Discounted Amount Of Insurance Related Assessment Liability LossContingencyDiscountedAmountOfInsuranceRelatedAssessmentLiability	175200000	USD
CY2017	us-gaap	Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability	162100000	USD
CY2018	us-gaap	Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability	180700000	USD
CY2017Q4	us-gaap	Loss Contingency Receivable LossContingencyReceivable	25800000	USD
CY2018Q4	us-gaap	Loss Contingency Receivable LossContingencyReceivable	32400000	USD
CY2018Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3338381000	USD
CY2018Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	11905000	USD
CY2018Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	33095000	USD
CY2018Q4	us-gaap	Long Term Debt LongTermDebt	3293381000	USD
CY2018	us-gaap	Interest Expense InterestExpense	198493000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	235552000	USD
CY2018Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year5 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear5	213000	USD
CY2018Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	43865000	USD
CY2018Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	26052000	USD
CY2018Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	710567000	USD
CY2018Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1259458000	USD
CY2018Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	240335000	USD
CY2018Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1058104000	USD
CY2018Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3338381000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2744080000	USD
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	13924000	USD
CY2017Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	30254000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	2699902000	USD
CY2017Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2761735000	USD
CY2016	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1426000	shares
CY2017	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1598000	shares
CY2018	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1491000	shares
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	202000	shares
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	227000	shares
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	185000	shares
CY2016	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	82000	shares
CY2017	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	27000	shares
CY2018	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	168000	shares
CY2016	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	232000	shares
CY2017	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	280000	shares
CY2018	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	357000	shares
CY2018Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000.0	USD
CY2018Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	185200000	USD
CY2016	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4217460000	USD
CY2016	sem	Adjusted Ebitda AdjustedEbitda	465807000	USD
CY2016Q4	us-gaap	Assets Assets	4920626000	USD
CY2016	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	161633000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4365245000	USD
CY2017	sem	Adjusted Ebitda AdjustedEbitda	537992000	USD
CY2017Q4	us-gaap	Assets Assets	5127166000	USD
CY2017	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	233243000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5081258000	USD
CY2018	sem	Adjusted Ebitda AdjustedEbitda	645155000	USD
CY2018Q4	us-gaap	Assets Assets	5964265000	USD
CY2018	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	167281000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	299847000	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11626000	USD
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19943000	USD
CY2016	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	42651000	USD
CY2016	us-gaap	Interest Expense InterestExpense	170081000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	180734000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	355878000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19719000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21054000	USD
CY2017	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-49000	USD
CY2017	us-gaap	Interest Expense InterestExpense	154703000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	202461000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	417279000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14155000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21905000	USD
CY2018Q4	sem	Deferred Tax Assets Disallowed Interest Carryforwards DeferredTaxAssetsDisallowedInterestCarryforwards	4675000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6591000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5695000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.021
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	105000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.18
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y10M24D
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	291775	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.26
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	185275	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.30
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1500	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	10.00
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	800000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1600000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1800000	USD
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	600000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17413000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	19284000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23326000	USD
CY2018Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear1	22998000	USD
CY2018Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year2 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear2	16566000	USD
CY2018Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year3 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear3	8976000	USD
CY2018Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year4 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear4	3302000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	54726000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	45809000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	36072000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	13329000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8331000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	15321000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	68055000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	54140000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	51393000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12591000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-72324000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7217000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55464000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18184000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58610000	USD
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.036
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.037
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.050
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.014
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.017
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	-0.067
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.002
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.073
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.005
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.013
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.006
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.008
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.005
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.005
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.021
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.007
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.013
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.022
CY2016	sem	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rate State Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateStatePercent	0
CY2017	sem	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rate State Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateStatePercent	-0.028
CY2018	sem	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rate State Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateStatePercent	0.004
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.375
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.003
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.004
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.010
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.307
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.090
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.249
CY2017	sem	Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit	-71500000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	8792000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	10313000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	50936000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	51900000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	11036000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	13644000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	319000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	209000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	36112000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	40163000	USD
CY2017Q4	sem	Deferred Tax Assets Disallowed Interest Carryforwards DeferredTaxAssetsDisallowedInterestCarryforwards	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	1452000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	2055000	USD
CY2017	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	5751000	USD
CY2018	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	4548000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	111890000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3543000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3271000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	118781000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	131925000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12986000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17893000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	105795000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	114032000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	19608000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	13891000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	4457000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	5653000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	179055000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	217950000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	4528000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	8324000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3673000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3488000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	211321000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	249306000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	105526000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	135274000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	19391000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	18621000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	124917000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	153895000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	105526000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	135274000	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-13400000	USD
CY2017	sem	Valuation Allowance Deferred Tax Asset Increase Decrease Federal Net Operating Losses Acquired In Business Combination Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFederalNetOperatingLossesAcquiredInBusinessCombinationAmount	-14100000	USD
CY2017	sem	Valuation Allowance Deferred Tax Asset Increase Decrease Expired State Net Operating Losses Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseExpiredStateNetOperatingLossesAmount	-200000	USD
CY2017	sem	Valuation Allowance Deferred Tax Asset Increase Decrease Newly Generated State Net Operating Losses Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseNewlyGeneratedStateNetOperatingLossesAmount	900000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4900000	USD
CY2018	sem	Valuation Allowance Deferred Tax Asset Increase Decrease Net Operating Losses Acquired In Business Combination Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseNetOperatingLossesAcquiredInBusinessCombinationAmount	3900000	USD
CY2018	sem	Valuation Allowance Deferred Tax Asset Increase Decrease Change In State Net Operating Losses Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseChangeInStateNetOperatingLossesAmount	1000000.0	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	105500000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	135300000	USD
CY2018	sem	Deferred Tax Asset Periodof Reviewfor Entitieswith Cumulative Losses DeferredTaxAssetPeriodofReviewforEntitieswithCumulativeLosses	P3Y
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.88
CY2016	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	3517000	USD
CY2016	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4022000	shares
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.87
CY2018	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.25
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	14700000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	15200000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	19500000	USD
CY2018	us-gaap	Earnings Per Share Basic Distributed EarningsPerShareBasicDistributed	0
CY2016	us-gaap	Profit Loss ProfitLoss	125270000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	220645000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	176942000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	125270000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	220645000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	176942000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9859000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43461000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	39102000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9859000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43461000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	39102000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	115411000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	137840000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	115411000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	137840000	USD
CY2016	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	3521000	USD
CY2017	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	5758000	USD
CY2018	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	4551000	USD
CY2016	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	3517000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	23463000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	51300000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	171426000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	133289000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	111894000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	171433000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	133292000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	133289000	USD
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130172000	shares
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.02
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	133292000	USD
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	130256000	shares
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.02
CY2018	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	4551000	USD
CY2018	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4444000	shares
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.02
CY2018	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	4548000	USD
CY2018	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4444000	shares
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.02
CY2018	us-gaap	Net Income Loss NetIncomeLoss	137840000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	137840000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	171426000	USD
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128955000	shares
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	171433000	USD
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	129126000	shares
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.33
CY2017	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	5758000	USD
CY2017	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4332000	shares
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2017	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	5751000	USD
CY2017	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4332000	shares
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.33
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	111890000	USD
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127813000	shares
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.88
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	111894000	USD
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127968000	shares
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.87
CY2016	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	3521000	USD
CY2016	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4022000	shares
CY2016	us-gaap	Net Income Loss NetIncomeLoss	115411000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	115411000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	24824000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	121058000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	261915000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	224306000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	185587000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	142655000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	104866000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	470694000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1390023000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	265100000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	267400000	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	307800000	USD
CY2016	sem	Operating Leases Facility Rent Expense Unrelated Parties OperatingLeasesFacilityRentExpenseUnrelatedParties	220800000	USD
CY2017	sem	Operating Leases Facility Rent Expense Unrelated Parties OperatingLeasesFacilityRentExpenseUnrelatedParties	224200000	USD
CY2018	sem	Operating Leases Facility Rent Expense Unrelated Parties OperatingLeasesFacilityRentExpenseUnrelatedParties	262600000	USD
CY2017Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1091517000	USD
CY2017Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1102465000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1077014000	USD
CY2017Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1094249000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	91765000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	115663000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	72098000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	76352000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	15870000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	42055000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	18462000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	100797000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1252964000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1296210000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1267401000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1264683000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	108598000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	120561000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	99837000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	88283000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	43982000	USD
CY2018Q2	us-gaap	Profit Loss ProfitLoss	60559000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	42679000	USD
CY2018Q4	us-gaap	Profit Loss ProfitLoss	29722000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	33739000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	46511000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	32917000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	24673000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18

Files In Submission

Name	View Source	Status
0001628280-19-001659-index-headers.html	Edgar Link	pending
0001628280-19-001659-index.html	Edgar Link	pending
0001628280-19-001659.txt	Edgar Link	pending
0001628280-19-001659-xbrl.zip	Edgar Link	pending
a10kchart001.jpg	Edgar Link	pending
ex10kimage1.jpg	Edgar Link	pending
ex10kimage2.jpg	Edgar Link	pending
ex10kimage3.jpg	Edgar Link	pending
ex10kimage4.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
sem-12311810k.htm	Edgar Link	pending
sem-12311810kex1068.htm	Edgar Link	pending
sem-12311810kex1071.htm	Edgar Link	pending
sem-12311810kex211.htm	Edgar Link	pending
sem-12311810kex23.htm	Edgar Link	pending
sem-12311810kex311.htm	Edgar Link	pending
sem-12311810kex312.htm	Edgar Link	pending
sem-12311810kex321.htm	Edgar Link	pending
sem-12311810k_htm.xml	Edgar Link	completed
sem-20181231.xsd	Edgar Link	pending
sem-20181231_cal.xml	Edgar Link	unprocessable
sem-20181231_def.xml	Edgar Link	unprocessable
sem-20181231_lab.xml	Edgar Link	unprocessable
sem-20181231_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SEM
SELECT MEDICAL HOLDINGS CORP Stock $sem

2018 Form 10-K Financial Statement

#000162828019001659 Filed on February 21, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEM SELECT MEDICAL HOLDINGS CORP Stock $sem

2018 Form 10-K Financial Statement

#000162828019001659 Filed on February 21, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEM
SELECT MEDICAL HOLDINGS CORP Stock $sem